Le Lézard
Classified in: Health

TIDI Products Adds New Gown to PPE Portfolio


NEENAH, Wis., Nov. 30, 2020 /PRNewswire/ --TIDI Products is pleased to announce an addition to its portfolio of personal protective equipment (PPE) to help keep healthcare workers safe.

Made in North America, TIDI's new Polyethylene Gowns provide AAMI Level 2 protection for caregivers. They offer an over-the-head style neck for easy donning and doffing, thumb loops to prevent sleeve slide, waist ties for a secure fit, and universal sizing.

"Our team recently identified a need for AAMI level 2 protection within our portfolio and made the idea of this new gown a reality in a matter of weeks," says Jeff Hebbard, Vice President and Chief Operations Officer. "We're excited to be able to bring this locally-produced PPE option to the market so quickly."

These new polyethylene gowns join the ranks of TIDI's additional PPE solutions, including eyewear and face shields. New TIDI face masks are also anticipated to launch in early 2021.

"At TIDI, we're always looking for new ways to deliver on our purpose to 'Support Caregivers, Protect Patients,'" says Leah Fichter, Senior Product Manager, PPE. "Our PPE portfolio has evolved throughout the pandemic, and we're proud of the way we've been able to support caregivers and customers during this time."

Individuals looking for more information or to place an order can call the TIDI Customer Service Team at 800-521-1314 or contact their medical supply distributor.

TIDI Products has a history of providing forward-looking solutions to healthcare professionals?solutions that help reduce the risk of contamination and deliver the highest-quality patient care. The TIDI Products portfolio of brands includes Posey®, C-Armor®, Sterile-Z®, PenBlade®, TIDIShield®, Grip-Lok®, and Zero-Gravity®. To learn more, visit www.tidiproducts.com.

CONTACT:
Catie Malooly
[email protected]

 

SOURCE TIDI Products, LLC


These press releases may also interest you

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....



News published on and distributed by: